Femoropopliteal in-stent restenosis: Current treatment strategies

Gagan Singh, E. J. Armstrong, J. R. Laird

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural complications and rates of stent fracture, femoropopliteal in-stent restenosis (FP-ISR) remains a common and important clinical problem. Due to heterogenous patient and angiographic characteristics, treatment of FP-ISR continues to evolve. Multiple modalities have been evaluated including standard balloon angioplasty, cutting or scoring balloon angioplasty, repeat stenting (nitinol stent vs. stent-graft vs. drug eluting stent), excisional or laser atherectomy, drug coated balloon angioplasty, and atherectomy followed by drug coated balloon angioplasty. This review highlights the clinical evidence for the currently available modalities in the treatment of FP-ISR. Future studies should utilize uniform classification schemes and assess similar outcomes to help determine the optimal approach for endovascular treatment of FP-ISR.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalJournal of Cardiovascular Surgery
Volume55
Issue number3
StatePublished - 2014

Fingerprint

Stents
Balloon Angioplasty
Atherectomy
Therapeutics
Drug-Eluting Stents
Peripheral Arterial Disease
Pharmaceutical Preparations
Lasers
Transplants

Keywords

  • Endovascular procedures
  • Ischemia
  • Sents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Femoropopliteal in-stent restenosis : Current treatment strategies. / Singh, Gagan; Armstrong, E. J.; Laird, J. R.

In: Journal of Cardiovascular Surgery, Vol. 55, No. 3, 2014, p. 325-333.

Research output: Contribution to journalArticle

Singh, Gagan ; Armstrong, E. J. ; Laird, J. R. / Femoropopliteal in-stent restenosis : Current treatment strategies. In: Journal of Cardiovascular Surgery. 2014 ; Vol. 55, No. 3. pp. 325-333.
@article{fb2de26c24924101b536eeed2cfb69ff,
title = "Femoropopliteal in-stent restenosis: Current treatment strategies",
abstract = "Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural complications and rates of stent fracture, femoropopliteal in-stent restenosis (FP-ISR) remains a common and important clinical problem. Due to heterogenous patient and angiographic characteristics, treatment of FP-ISR continues to evolve. Multiple modalities have been evaluated including standard balloon angioplasty, cutting or scoring balloon angioplasty, repeat stenting (nitinol stent vs. stent-graft vs. drug eluting stent), excisional or laser atherectomy, drug coated balloon angioplasty, and atherectomy followed by drug coated balloon angioplasty. This review highlights the clinical evidence for the currently available modalities in the treatment of FP-ISR. Future studies should utilize uniform classification schemes and assess similar outcomes to help determine the optimal approach for endovascular treatment of FP-ISR.",
keywords = "Endovascular procedures, Ischemia, Sents",
author = "Gagan Singh and Armstrong, {E. J.} and Laird, {J. R.}",
year = "2014",
language = "English (US)",
volume = "55",
pages = "325--333",
journal = "Journal of Cardiovascular Surgery",
issn = "0021-9509",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Femoropopliteal in-stent restenosis

T2 - Current treatment strategies

AU - Singh, Gagan

AU - Armstrong, E. J.

AU - Laird, J. R.

PY - 2014

Y1 - 2014

N2 - Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural complications and rates of stent fracture, femoropopliteal in-stent restenosis (FP-ISR) remains a common and important clinical problem. Due to heterogenous patient and angiographic characteristics, treatment of FP-ISR continues to evolve. Multiple modalities have been evaluated including standard balloon angioplasty, cutting or scoring balloon angioplasty, repeat stenting (nitinol stent vs. stent-graft vs. drug eluting stent), excisional or laser atherectomy, drug coated balloon angioplasty, and atherectomy followed by drug coated balloon angioplasty. This review highlights the clinical evidence for the currently available modalities in the treatment of FP-ISR. Future studies should utilize uniform classification schemes and assess similar outcomes to help determine the optimal approach for endovascular treatment of FP-ISR.

AB - Nitinol self-expanding stents are increasingly used to treat symptomatic peripheral arterial disease. Despite reduction in procedural complications and rates of stent fracture, femoropopliteal in-stent restenosis (FP-ISR) remains a common and important clinical problem. Due to heterogenous patient and angiographic characteristics, treatment of FP-ISR continues to evolve. Multiple modalities have been evaluated including standard balloon angioplasty, cutting or scoring balloon angioplasty, repeat stenting (nitinol stent vs. stent-graft vs. drug eluting stent), excisional or laser atherectomy, drug coated balloon angioplasty, and atherectomy followed by drug coated balloon angioplasty. This review highlights the clinical evidence for the currently available modalities in the treatment of FP-ISR. Future studies should utilize uniform classification schemes and assess similar outcomes to help determine the optimal approach for endovascular treatment of FP-ISR.

KW - Endovascular procedures

KW - Ischemia

KW - Sents

UR - http://www.scopus.com/inward/record.url?scp=84901819529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901819529&partnerID=8YFLogxK

M3 - Article

C2 - 24755700

AN - SCOPUS:84901819529

VL - 55

SP - 325

EP - 333

JO - Journal of Cardiovascular Surgery

JF - Journal of Cardiovascular Surgery

SN - 0021-9509

IS - 3

ER -